These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9121147)

  • 1. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma.
    Wagner JD; Schauwecker D; Hutchins G; Coleman JJ
    J Surg Oncol; 1997 Mar; 64(3):181-9. PubMed ID: 9121147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
    Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
    J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
    Macfarlane DJ; Sondak V; Johnson T; Wahl RL
    J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
    Crippa F; Leutner M; Belli F; Gallino F; Greco M; Pilotti S; Cascinelli N; Bombardieri E
    J Nucl Med; 2000 Sep; 41(9):1491-4. PubMed ID: 10994727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.
    Wagner JD; Schauwecker DS; Davidson D; Wenck S; Jung SH; Hutchins G
    J Surg Oncol; 2001 Aug; 77(4):237-42. PubMed ID: 11473371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
    Havenga K; Cobben DC; Oyen WJ; Nienhuijs S; Hoekstra HJ; Ruers TJ; Wobbes T
    Eur J Surg Oncol; 2003 Oct; 29(8):662-4. PubMed ID: 14511614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
    Belhocine T; Pierard G; De Labrassinne M; Lahaye T; Rigo P
    Oncologist; 2002; 7(4):271-8. PubMed ID: 12185291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
    Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma.
    Blessing C; Feine U; Geiger L; Carl M; Rassner G; Fierlbeck G
    Arch Dermatol; 1995 Dec; 131(12):1394-8. PubMed ID: 7492127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
    Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
    Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
    J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.
    Acland KM; Healy C; Calonje E; O'Doherty M; Nunan T; Page C; Higgins E; Russell-Jones R
    J Clin Oncol; 2001 May; 19(10):2674-8. PubMed ID: 11352959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
    Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
    Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
    Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
    Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.